Medical Abortion at Gestational Age of 8 to ≤9 Weeks Versus >9 to ≤12 Weeks
- Registration Number
- NCT02745093
- Lead Sponsor
- Ibis Reproductive Health
- Brief Summary
The purpose of this study is to assess the effectiveness, safety, and acceptability of home-administered medical abortion at gestational age of 8 to ≤9 weeks versus \>9 to ≤12 weeks among a cohort of women in Mexico City.
- Detailed Description
Medical abortion represents an important alternative to surgical methods for termination of early pregnancy. In Mexico City, abortion is legal on request up to 12 weeks of gestation; however, medical abortion is currently only offered up to 10 weeks at Marie Stopes Mexico clinics. The World Health Organization guidelines state that medical abortion drugs may be used to terminate pregnancy up to a gestational age of 24 weeks in clinical settings, with recommended regimens differing by gestational age. However, data are lacking on the safety and effectiveness of home-based medical abortion regimens for pregnancy terminations between \>9 and ≤12 weeks' gestation. Investigators propose a prospective cohort study with women between 8 and ≤9 weeks and \>9 and ≤12 weeks of pregnancy at Marie Stopes Mexico clinics to compare the effectiveness, safety, and acceptability of mifepristone followed by home-based misoprostol use in these two gestational age groups. The information from this study will inform policy and practice guidelines in Mexico City and potentially other locations by providing evidence on the safety, effectiveness, and acceptability of home-use of medical abortion between \>9 and ≤12 weeks of gestation.
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- Female
- Target Recruitment
- 648
- Aged 18 or older
- Intrauterine pregnancy 57- 84 days, assessed using clinical assessment and transvaginal or transabdominal ultrasound by crown-rump length (machines will be calibrated and will use a standardized conversion formula to determine gestational age)
- Eligible for medical abortion according to doctor assessment
- Elected medical abortion over surgical abortion after comprehensive counselling
- Haemoglobin level ≥10 g/dl measured by Hemocue
- Willing and able to sign consent forms
- Able to speak and read Spanish
- Agree to comply with the study procedures and visit schedule
- Access to own telephone and to emergency transportation
- Access to a toilet with privacy
- Reside no more than 30 minutes car journey from the Sta. Mónica Hospital in Polanco or the Marie Stopes Mexico Roma Clinic
- History or evidence of disorders that represent a contraindication to the use of mifepristone or misoprostol (chronic adrenal failure, severe asthma uncontrolled by corticosteroid therapy, inherited porphyries, glaucoma, mitral stenosis, hepatic or renal disease)
- History of bleeding disorder or current anticoagulant therapy
- Previous allergic reaction to any drugs in the regimen
- Suspicion of any pathology of pregnancy (e.g. molar, ectopic, non-viable pregnancy)
- Multiple gestation
- Presence of an intrauterine device
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description 64-84 days gestational age Mifepristone Women whose pregnancies are estimated to have a gestational age of 64-84 days will receive 200 µg mifepristone followed by misoprostol 24-48 hours later. 64-84 days gestational age Misoprostol Women whose pregnancies are estimated to have a gestational age of 64-84 days will receive 200 µg mifepristone followed by misoprostol 24-48 hours later.
- Primary Outcome Measures
Name Time Method Proportion of participants with complete abortion without surgical intervention by day 30 from mifepristone administration, regardless of misoprostol dosing, by gestational age group 2-4 weeks
- Secondary Outcome Measures
Name Time Method Proportion of participants by gestational age group with complete abortion without surgical intervention after 1, 2, 3, 4, and 5 doses of misoprostol, by gestational age group 2-4 weeks Number of participants who called the helpline, by gestational age group 2-4 weeks Proportion of participants who saw products of pregnancy who reported feelings as: nothing/no feeling, relieved, sad, uncomfortable, other, by gestational group 2-4 weeks Received family planning by follow-up visit, by gestational age group / method type/ pregnancy intention 2-4 weeks Satisfied or very satisfied with abortion method, by gestational age group 2-4 weeks Would recommend abortion method to a friend, by gestational age group 2-4 weeks Proportion of participants who saw products of pregnancy, by gestational age group 2-4 weeks Experience of any major adverse event overall, and by type (emergency room treatment, hospitalization, transfusion, unrecognized ectopic pregnancy, allergic reaction, infection requiring intravenous treatment, and death), by gestational age group 2-4 weeks Number of participants requiring surgical intervention to complete an abortion due to an ongoing pregnancy, by gestational age group 2-4 weeks Number of participants requiring surgical intervention to complete an abortion due to substantial debris in uterus, by gestational age group 2-4 weeks Number of participants requiring surgical intervention to complete an abortion due to woman's request, by gestational age group 2-4 weeks Time to expulsion in days, by gestational age group 2-4 weeks Pain reliever use 2-4 weeks Would choose medical abortion again instead of surgical, by gestational age group 2-4 weeks Number of participants requiring surgical intervention to complete an abortion due to excessive prolonged bleeding indicated as severe on the adverse event form, by gestational age group 2-4 weeks Side effects overall and by type (chills, fever, vomiting, nausea, diarrhoea, and severe pain), by gestational age group 2-4 weeks Duration of heavy bleeding, by gestational age group 2-4 weeks Duration of work or school missed, by gestational age group 2-4 weeks Did not receive a contraceptive method by follow-up visit, but don't want to get pregnant in next 12 months, by gestational age group 2-4 weeks Number of participants requiring surgical intervention to complete an abortion due to the presence of a persistent non-viable sac, by gestational age group 2-4 weeks Number of participants requiring an unscheduled clinic visit, by gestational age group 2-4 weeks Know where to get contraceptive supplies in the future, by gestational age group and pregnancy intention 2-4 weeks
Trial Locations
- Locations (3)
Marie Stopes Mexico Azcapotzalco
🇲🇽Del. Azcapotzalco, Mexico Distrito Federal, Mexico
Marie Stopes Mexico Pedregal
🇲🇽Del. Tlalpan, Mexico Distrito Federal, Mexico
Marie Stopes Mexico Roma
🇲🇽Del. Cuauhtémoc, Mexico Distrito Federal, Mexico